Retinopathy of prematurity (ROP) is one of the most common causes of severe visual impairment and blindness in children worldwide. Because the blood vessels in the retina are not fully developed, ...
Swedish researchers find that daily cortisone eye drops reduce the chance that babies with ROP will require further invasive interventions ...
DelSiTech Ltd. today announced an exclusive licensing agreement pertaining to the development of controlled-release dexamethasone eye drops utilizing DelSiTech™ Silica Matrix technology. Dexamethasone ...
Optifye Therapeutics has struck a deal with DelSiTech for controlled-release dexamethasone eye drops. The exclusive license agreement covers a candidate that uses DelSiTech Silica Matrix technology to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. PARK CITY, Utah — Stage one of the phase 3 DIAMOND trial ...
Please provide your email address to receive an email when new articles are posted on . Putting an eye drop in a young kid’s eye is tough. Putting an eye drop in your own young kid’s eye is impossible ...
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results